Sunitinib versus interferon alfa in metastatic renal-cell carcinoma (mRCC): updated efficacy and safety results and further analysis of prognostic factors. - Motzer,R.J.; Michaelson,M.D.; Hutson,T.E. (Eur J Cancer, 2007)